Nothing Special   »   [go: up one dir, main page]

Bende et al., 2009 - Google Patents

Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas

Bende et al., 2009

View HTML
Document ID
4719108378199605856
Author
Bende R
Van Maldegem F
Van Noesel C
Publication year
Publication venue
haematologica

External Links

Snippet

Chronic autoimmune or pathogen-induced immune reactions resulting in lymphoid neogenesis are associated with development of malignant lymphomas, mostly extranodal marginal zone B-cell lymphomas (MZBCLs). In this review we address (i) chemokines and …
Continue reading at pmc.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant

Similar Documents

Publication Publication Date Title
Bende et al. Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas
Frasca et al. B cell immunosenescence
Rodriguez-Zhurbenko et al. Human B-1 cells and B-1 cell antibodies change with advancing age
Palm et al. Remembrance of things past: long-term B cell memory after infection and vaccination
Herold et al. Type 1 diabetes: translating mechanistic observations into effective clinical outcomes
Tangye et al. Human IgM+ CD27+ B cells: memory B cells or “memory” B cells?
Ansel et al. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity
Lutzky et al. Cells of the synovium in rheumatoid arthritis. Dendritic cells
Mapara et al. Expression of chemokines in GVHD target organs is influenced by conditioning and genetic factors and amplified by GVHR
Morbach et al. Activated memory B cells may function as antigen‐presenting cells in the joints of children with juvenile idiopathic arthritis
Bende et al. Stereotypic rheumatoid factors that are frequently expressed in mucosa‐associated lymphoid tissue–type lymphomas are rare in the labial salivary glands of patients with Sjögren's syndrome
Chang et al. Innate immunity drives the initiation of a murine model of primary biliary cirrhosis
US20210236513A1 (en) Novel uses
Moshkani et al. CD23+ CD21highCD1dhigh B cells in inflamed lymph nodes are a locally differentiated population with increased antigen capture and activation potential
Trujillo et al. 7 Quantitative and Functional Evaluation of Innate Immune Responses in Patients With Common Variable Immunodeficiency
US20210236512A1 (en) Clozapine for the treatment of a immunoglobulin driven b cell disease
Puga et al. B–helper neutrophils stimulate immunoglobulin diversification and production in the marginal zone of the spleen
Dunn-Walters et al. Older Human B Cells and Antibodies
Gronke et al. Human Th17-and IgG3-associated autoimmunity induced by a translocating gut pathobiont
Bende B cell biology and the development of mature B cell lymphomas
Ogishi et al. Impaired development of memory B cells and antibody responses in humans and mice deficient in PD-1 signaling
Golby et al. Human tonsillar germinal center T cells are a diverse and widely disseminated population
Zhou et al. A germinal center checkpoint of AIRE in B cells limits antibody diversification
He Identification and functional analysis of anti-citrullinated protein antibodies in rheumatoid arthritis
Cai Analysis of antibodies to cartilage oligomeric matrix protein in rheumatoid arthritis and in mouse models